Novonesis (0Q4U) Stock Statistics & Valuation Metrics

Novonesis has a market cap or net worth of kr182.98B. The enterprise value is kr233.48B.

Novonesis has 414,555,050 shares outstanding. The number of shares has decreased by -2.65% in one year.

Novonesis’s return on equity (ROE) is <0.01 and return on invested capital (ROIC) is 3.36%.

The current PE Ratio of Novonesis is 78.2. Novonesis’s PEG ratio is ―.

In the last 12 months, Novonesis had revenue of 3.83B and earned 305.80M in profits. Earnings per share was 1.10.

In the last 12 months, operating cash flow was 4.40B and capital expenditures -1.06B, giving a free cash flow of 3.34B billion.

Novonesis pays an annual dividend of ―, resulting in a dividend yield of ―

Novonesis upcoming earnings date is Feb 25, 2026, Before Open (Confirmed).

Novonesis as a current ratio of 1.73, with Debt / Equity ratio of 30.92%

In the past 12 months, Novonesis has paid 111.30M in taxes.

Novonesis EV to EBITDA ratio is 2.07, with an EV/FCF ratio of 25.30.

Novonesis has kr2.31B in cash and marketable securities with kr1.70B in debt, giving a net cash position of -kr20.89B billion.

Gross margin is 58.42%, with operating margin of 17.19%, and net profit margin of 7.98%.

The average price target for Novonesis is kr485.00, which is 11.43% higher than the current price. The consensus rating is Strong Buy